Latest Blogs
- Latest CDC Findings: A Wake‑Up Call for the $1.3 Billion Global Sepsis Diagnostics Market April 6, 2026
- NAMs, NIH Policy, and What it Means for Diagnostics March 20, 2026
- As Flu Outpaces COVID This Winter, Rapid Molecular Testing Takes on New Importance March 17, 2026
- March Is Colorectal Cancer Awareness Month: How Liquid Biopsy Is Shaping the Future of CRC Detection and Care February 20, 2026
- Global IVD Growth: Stability, Shifting Markets, and the Road to 2030 February 11, 2026
Sitemap
Your Data and Privacy
About Us
Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.
Visit Science and Medicine Group
Visit Science and Medicine Group

10 Developments at AACC 2022 in Chicago, Per Kalorama Information
Kalorama Information’s market analysts are at the 2022 American Association for Clinical Chemistry (AACC) expo in Chicago. They have observed the following notable developments from AACC today: Biosensor Wins Award: Nanopath’s proprietary solid-state biosensing platform utilizes ultrasensitive optical detection, which eliminates the need for nucleic acid amplification, and provides clinically actionable genetic information in less […]
China a Major Presence at #AACC2022
There’s no doubt about it, China is a key healthcare market player. Major indicators of China’s burgeoning impact on healthcare include its overall population growth, aging population growth, chronic disease status, and health resources. Proof of China’s presence in the market has been on full display at the 2022 American Association for Clinical Chemistry (AACC) […]
What We Are Looking Forward to at AACC 2022
As the laboratory and IVD industry gears up for what’s expected to be the largest in-person meeting since the COVID-19 pandemic, our editors and analysts will be in Chicago and on the scene. We see several issues on the horizon that we’ll be curious to see how laboratorians and IVD industry leaders address. Lab labor […]
Due to Clinical Laboratory Services, Doctors Can Treat Patients Like Never Before
Global clinical laboratory services market is $168 billion and growing, finds new market research report by Kalorama Information Clinical laboratories are an essential part of the health industry, and as a result the global market for clinical laboratory services grew to an estimated $168.3 billion in 2021 (including $79 billion generated from markets outside the […]
This Week in Cell and Gene Therapy: 10 New Developments to Know (July 11, 2022)
This Week in Cell and Gene Therapy: 14 New Developments to Know (June 27, 2022)
In Vitro Diagnostics Business Outlook: Blood Typing Has Rebounded
In 2021, the world market for blood grouping and blood typing rebounded from a 3.2% decline in 2020 due to COVID-19 impacts, reaching an estimated $945 million in revenues, according to an upcoming issue of the In Vitro Diagnostics Business Outlook. The overall market is expected to stabilize in 2022 and grow at a 1% […]
This Week in Cell and Gene Therapy: 12 New Developments to Know (June 13, 2022)
The Middle East and Africa Region a $4 Billion Hotbed for IVD Investment
Globally, in vitro diagnostic (IVD) companies are exploring opportunities in developing countries, where rising incomes and standards of living have sparked a new health consciousness and growing demands for quality medical care. As the COVID-19 dust settles, it is expected that the interest in geographic expansion will once again return to the Middle East and […]
Single Cell Genomics in Next-Generation Sequencing (NGS) Market Reaches $780 Million